Michael S. Cloutier
Vorstandsvorsitzender bei 5WH Leadership
Profil
Michael S.
Cloutier is currently the President & Chief Executive Officer at LEXORC Performance Solutions, Inc., 5WH Leadership, Director at HydRx Farms Ltd., Director & Founding Partner at Accelera Canada Ltd., and Director at Alimentiv, Inc. In the past, he served as President & Chief Executive Officer at AstraZeneca Canada, Inc., Diabetes Canada, and Pharmacia Canada, Inc. He was also the Vice President-Human Resources & Global Marketing at AstraZeneca PLC, President & General Manager at InterMune, Inc., Vice President & General Manager at PTC Therapeutics, Inc., and President at Searle Canada, Inc. Additionally, he held positions as Chairman-Governors Board at Sheridan College and Canadian Stroke Network, Vice Chairman at Canadian Orthopaedic Foundation, Director at Cotinga Pharmaceuticals, Inc., Independent Non-Executive Director at Merus Labs International, Inc., and Partner at Mirador Global LP.
Aktive Positionen von Michael S. Cloutier
Unternehmen | Position | Beginn |
---|---|---|
LEXORC Performance Solutions, Inc. | Vorstandsvorsitzender | - |
5WH Leadership
5WH Leadership Miscellaneous Commercial ServicesCommercial Services 5WH Leadership engages in the provision of leadership development with training and coaching programs. The company is headquartered in Burlington, Canada. | Vorstandsvorsitzender | 08.09.2009 |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | Direktor/Vorstandsmitglied | - |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | Direktor/Vorstandsmitglied | - |
Accelera Canada Ltd.
Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael S. Cloutier
Unternehmen | Position | Ende |
---|---|---|
Diabetes Canada
Diabetes Canada Miscellaneous Commercial ServicesCommercial Services Diabetes Canada operates as a registered national charitable organization that is making the invisible epidemic of diabetes visible and urgent. The firm partners with Canadians to end diabetes through educational programs and support services, resources for health-care professionals, advocacy to governments, schools and workplaces and funding Canadian research. The company was founded by Charles Best in 1953 and is headquartered in Toronto, Canada. | Präsident | 01.01.2013 |
COTINGA PHARMACEUTICALS INC. | Präsident | 06.09.2010 |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Präsident | 01.01.2007 |
Pharmacia Canada, Inc. | Präsident | 01.01.2003 |
░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
COTINGA PHARMACEUTICALS INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 14 |
---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
Pharmacia Canada, Inc. | |
Searle Canada, Inc. | |
Canadian Orthopaedic Foundation | |
5WH Leadership
5WH Leadership Miscellaneous Commercial ServicesCommercial Services 5WH Leadership engages in the provision of leadership development with training and coaching programs. The company is headquartered in Burlington, Canada. | Commercial Services |
Canadian Stroke Network
Canadian Stroke Network Miscellaneous Commercial ServicesCommercial Services Canadian Stroke Network operates as a non-profit healthcare organization. The company was founded in 1999 and is headquartered in Ottawa, Canada. | Commercial Services |
LEXORC Performance Solutions, Inc. | |
Diabetes Canada
Diabetes Canada Miscellaneous Commercial ServicesCommercial Services Diabetes Canada operates as a registered national charitable organization that is making the invisible epidemic of diabetes visible and urgent. The firm partners with Canadians to end diabetes through educational programs and support services, resources for health-care professionals, advocacy to governments, schools and workplaces and funding Canadian research. The company was founded by Charles Best in 1953 and is headquartered in Toronto, Canada. | Commercial Services |
Merus Labs International, Inc.
Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Mirador Global LP
Mirador Global LP Miscellaneous Commercial ServicesCommercial Services Mirador Global LP provides consulting services to specialty diseases. It provides drug commercialization assessment and launch planning services in Oncology, Immuno-Oncology, Orphan and CNS for small and medium-sized bio-pharma companies around the world. The company was founded by Chuck Peipher in 2016 and is headquartered in Kennett Square, PA. | Commercial Services |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | Process Industries |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | Health Technology |
Accelera Canada Ltd.
Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Commercial Services |